Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Trade Desk Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while Trade Desk Inc trades at $11.92 (market cap $5.76B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Trade Desk Inc for 73 Days on average.
| HNGE | TTD | |
|---|---|---|
Market Cap | $8.47B | $5.76B |
Volume | 1,624,526 | 17,724,516 |
Sector | Health | Media |
52-Week High | $105.14 | $54.13 |
52-Week Low | $31.17 | $11.92 |
Typical Hold Time | 0 Days | 73 Days |
Enterprise Value | $8.09B | $4.71B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
The Trade Desk (TTD) trades at $12.17, down 68% year-to-date amid a bearish technical outlook and slowing revenue growth. Recent earnings show mixed results with a Q2 beat but a Q1 miss, while Q3 2026 guidance indicates a 12% revenue decline. The company maintains strong profitability margins and a low P/E ratio, but faces intense competition from tech giants and has announced workforce reductions.
The stock presents a high-risk opportunity with a consensus price target of $14.68 offering potential upside, though near-term headwinds from competition and index removal flows persist. Long-term prospects hinge on the company's ability to defend its open internet ad platform against Amazon and Google while restoring growth momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
